Beta-lactam-fosfomycin antagonism involving modification of penicillin-binding protein 3 in Pseudomonas aeruginosa.
Antimicrob Agents Chemother
; 34(11): 2093-6, 1990 Nov.
Article
em En
| MEDLINE
| ID: mdl-2127343
Antagonism between fosfomycin and antipseudomonal penicillins, cefotaxime, and ceftriaxone was observed in Pseudomonas aeruginosa RYC212. Fosfomycin, a non-beta-lactam antibiotic that acts on bacterial cell wall synthesis, decreased the expression of penicillin-binding protein 3 and induced beta-lactamase. The antagonistic effect was reduced in the presence of high concentrations of the beta-lactamase inhibitor tazobactam or in fosfomycin-resistant mutants. We suggest that products resulting from fosfomycin cell wall damage could interact with a system that regulates penicillin-binding protein and beta-lactamase production.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Pseudomonas aeruginosa
/
Proteínas de Bactérias
/
Muramilpentapeptídeo Carboxipeptidase
/
Proteínas de Transporte
/
Peptidil Transferases
/
Fosfomicina
/
Hexosiltransferases
/
Antibacterianos
/
Complexos Multienzimáticos
Idioma:
En
Ano de publicação:
1990
Tipo de documento:
Article